Progress continues in treating pediatric skin ailments

Article

National report ? While topical calcineurin inhibitors for treating atopic dermatitis (AD) continue to grab headlines, sources tell Dermatology Times that research into additional treatments for pediatric skin problems is progressing.

Related Videos
Related Content

SARS-CoV-2 Associated With Increased Incidence of Psoriasis

October 3rd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Discovering Last Month's Psoriasis Spotlight

October 3rd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Get Ready to Test Your Atopic Dermatitis Knowledge

October 2nd 2023

Risankizumab Efficacious in Patients With Concomitant Psoriasis and HIV, Study Reports

October 2nd 2023

SARS-CoV-2 Associated With Increased Incidence of Psoriasis

October 3rd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Discovering Last Month's Psoriasis Spotlight

October 3rd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Get Ready to Test Your Atopic Dermatitis Knowledge

October 2nd 2023

Risankizumab Efficacious in Patients With Concomitant Psoriasis and HIV, Study Reports

October 2nd 2023

SARS-CoV-2 Associated With Increased Incidence of Psoriasis

October 3rd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Discovering Last Month's Psoriasis Spotlight

October 3rd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Get Ready to Test Your Atopic Dermatitis Knowledge

October 2nd 2023

Risankizumab Efficacious in Patients With Concomitant Psoriasis and HIV, Study Reports

October 2nd 2023
© 2023 MJH Life Sciences

All rights reserved.